Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Seven Days In March: NDA-BLA and ANDA Approval Output Diverged As Coronavirus Teleworking Began
Apr 30 2020
•
By
Derrick Gingery
The coronavirus outbreak forced changes to FDA workflow and priorities, which may have affected NDA-BLA approval output. • Source: Shutterstock
More from Product Reviews
More from Pink Sheet